Kodiak Sciences Completes Enrollment in First Pivotal Cohort in the Phase 3 PEAK Trial of KSI-101 for Macular Edema Secondary to Inflammation and Reaffirms Topline Clinical Data Release Remains on Tra
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| (NASDAQ: KOD) | Delayed: 87.72 -5.25 (5.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.97 | 52 Week High | $ | |||
| Open | $91.14 | 52 Week Low | $ | |||
| Day High | $94.64 | P/E | N/A | |||
| Day Low | $87.29 | EPS | $ | |||
| Volume | 943,102 | |||||
